Bohl J, Störkel S, Steinmetz H
Department of Neuropathology and Pathology, Johannes Gutenberg-University, Mainz, FRG.
Prog Clin Biol Res. 1989;317:1007-19.
The list of human amyloidoses contains at least ten different types that might be differentiated on account of their pattern of distribution (localized or generalized), on the basis of their underlying diseases and above all on account of their different amyloidogenic proteins. According to WRIGHT it was already possible to differentiate two types of amyloid by pretreating the histologic tissue sections with KMnO4 before staining them with Congored. But now nearly all different types of amyloid can be determined immunohistologically by means of specific antibodies. In the human brain and in its coverings we found as well localized as generalized amyloidoses. The most frequent localized amyloidosis is the cerebral amyloidosis in Alzheimer's disease, in senile dementia of the Alzheimer type and in "normal" aging (type ASb). The endocrine type of amyloid could be detected in the anterior pituitary lobe of old people and sometimes in adenomas of the pituitary gland (type AE). In cases of generalized amyloidosis (e.g. amyloid type AA, type AF or type AL) the intracranial amyloid deposits or precipitations are only found in those regions where the blood brain barrier is insufficient. These regions are --choroid plexus --infundibulum (hypothalamus) --pineal gland (epiphysis) --area postrema --circumventricular organs --ganglion Gasseri and --dura mater. The other parts of the CNS (the leptomeninges, cortical grey matter, subcortical white matter and basal ganglia) are always free of amyloid in these cases of generalized amyloidosis. In cases of cerebral amyloidosis (type ASb) the typical berefringent Congored deposits are found in the leptomeninges and in cortical and subcortical grey matter; white matter and all other regions are always free of amyloid. We observed several cases with more than one type of amyloidosis: e.g. a generalized form and a second local amyloidosis, two generalized forms (AA and A beta 2M) or even several localized types (ASb, AE). By paying attention to the typical distribution pattern of the amyloid deposits in the CNS and its coverings and by using specific antibodies it is now possible to distinguish between two different amyloidoses even in the same body region, e.g. in the human brain.
人类淀粉样变性疾病列表包含至少十种不同类型,可根据其分布模式(局部性或全身性)、潜在疾病,尤其是不同的淀粉样蛋白生成蛋白进行区分。根据赖特的说法,在用刚果红染色之前,先用高锰酸钾对组织学切片进行预处理,就已经能够区分两种类型的淀粉样蛋白。但现在几乎所有不同类型的淀粉样蛋白都可以通过特异性抗体进行免疫组织学检测。在人类大脑及其被膜中,我们发现了局部性和全身性淀粉样变性疾病。最常见的局部性淀粉样变性是阿尔茨海默病、阿尔茨海默型老年痴呆症和“正常”衰老(ASb型)中的脑淀粉样变性。在老年人的垂体前叶,有时在垂体腺瘤中可以检测到内分泌型淀粉样变性(AE型)。在全身性淀粉样变性(如AA型、AF型或AL型)的病例中,颅内淀粉样沉积物或沉淀物仅在血脑屏障不足的区域被发现。这些区域包括——脉络丛——漏斗(下丘脑)——松果体(松果体)——最后区——脑室周围器官——加塞神经节和——硬脑膜。在这些全身性淀粉样变性病例中,中枢神经系统的其他部分(软脑膜、皮质灰质、皮质下白质和基底神经节)始终没有淀粉样蛋白。在脑淀粉样变性(ASb型)的病例中,在软脑膜以及皮质和皮质下灰质中发现了典型的折光刚果红沉积物;白质和所有其他区域始终没有淀粉样蛋白。我们观察到几例存在不止一种类型淀粉样变性的病例:例如,一种全身性形式和第二种局部性淀粉样变性、两种全身性形式(AA型和β2M型),甚至几种局部性类型(ASb型、AE型)。通过关注淀粉样沉积物在中枢神经系统及其被膜中的典型分布模式,并使用特异性抗体,现在即使在同一身体区域,如人类大脑中,也能够区分两种不同的淀粉样变性疾病。